Newsroom

Private Equity Magazine interview about TechLife Capital co-investment strategy

TechLife Capital Sponsor and Speakers at Healthcare Summit at 2024 IPEM Conference

Investment in Evolutis, a french knee hip and shoulder prosthetics designer, manufacturer​ and distributor

​

Investment in CNSI, an expert in e-commerce solutions for market places

​

​

La Jaune et La Rouge article about TechLife Capital : "Un double ADN investisseur et industriel pour accélérer la croissance des champions français et de HealthTech"

CF NEWS article about QUINTEN: 

"Quinten soigne son intelligence artificielle."

​

​

Investment in QUINTEN, a developer of algorithms and AI solutions for data processing and enhancement for all healthcare players

BIOTECH FINANCE article about TechLife Capital: 

"Growth Venture - TechLife Capital marie santé et tech."

DÉCIDEURS MAGAZINE article about MITEM: 

"Le laboratoire Mitem Pharma lève 10M€ auprès du fond TechLife Capital."

CF NEWS article about MITEM: 

"MITEM veut accélérer son développement et trouve écho auprès de Techlife qui injecte 10 M€."

Investment in MITEM Pharma, an agile pharmaceutical laboratory dedicated to Medicines of Major Therapeutics Interests 

Investment in MyData-Trust, a provider of outsourced data protection services and solutions for the biotech and pharma companies

Investment in Flash Therapeutics, a high-end designer and manufacturer of viral vectors for biotech companies (critical in gene, cell and mRNA therapies).

CFNews article about TechLife Capital:

« TechLife Capital se lance dans le growth en visant le numérique et la santé »

Acquisition of Maxxing, an editor of customer relationship and loyalty management software (SaaS)

​

Private Equity Magazine article about TechLife Capital: « TechLife Capital creuse les filières d’avenir en santé et en technologie »

TechLife Capital receives a Financing Innovation label from the French Ministry of Economy (Tibi Initiative).

Launch of XPath, a consolidation platform in cancer diagnosis services and investment in the two first laboratories

​